A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

Drugmakers combine a chemotherapy drug with a monoclonal antibody designed to recognize and bind to a specific protein found ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

Monoclonal antibodies are biologic drugs (protein drugs made using living ... and various types of cancer. Interaction result: Taking Rystiggo with a monoclonal antibody can make the monoclonal ...

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...